Healthcare Stocks
Latest news, explainers and analysis on Healthcare Stocks. Tracking 10 stories on Arth Vani.
Connected in the graph
Latest on Healthcare Stocks
Yatharth Hospitals Stock Surges 10% to Record High on Advent's Stake Deal
Yatharth Hospitals shares hit a fresh record high, climbing 10% after news that private equity firm Advent International is set to acquire a 25% stake. The stock has now risen 20% recently, indicating strong investor interest following the potential deal.
Danaher vs. Medtronic: Analysis of Global Healthcare Recovery Potential
Due to the absence of source content, a detailed summary comparing Danaher and Medtronic's recovery potential cannot be provided. This report would typically analyze their financial health, market position, and growth drivers to offer investment insights.
Thermo Fisher vs. Intuitive Surgical: A Global Healthcare Stock Valuation Debate
This report is unable to provide a summary as the detailed content comparing Thermo Fisher Scientific and Intuitive Surgical's valuations was not provided in the source material. We cannot analyze which premium healthcare stock deserves its current valuation without the underlying financial data and analysis.
Medtronic, Thermo Fisher: Global Healthcare Stock Outlook for Investors
This report would typically compare healthcare giants Medtronic and Thermo Fisher, analyzing their turnaround strategies and identifying potential investment upsides. However, the original article content was not provided, preventing a factual deep dive.
J&J's $5.5 Billion Talc Settlement: A Clear Path or Lingering Legal Cloud?
Johnson & Johnson (J&J) has proposed a $5.5 billion (approximately ₹45,800 crore) settlement to resolve a significant portion of lawsuits alleging its talc products caused cancer. This move prompts investors to question whether the substantial offer signals an end to the company's prolonged legal challenges or if significant risks still loom.
IPOBreakingMolbio Diagnostics Raises ₹281 Crore From Anchor Investors Ahead of IPO Launch
Goa-based Molbio Diagnostics has secured ₹281.5 crore from institutional anchor investors as it prepares for its public market debut. The company plans to raise up to ₹940 crore to fund manufacturing expansion and infrastructure upgrades.
IPOBreakingManipal Health Shares List at 11% Premium: Investors Book Gains on Market Debut
Manipal Health made a positive debut on the stock exchanges today, listing at a premium of over 11% against its issue price. The shares opened at ₹652 on the NSE and ₹655 on the BSE, rewarding successful allottees with immediate listing gains.
Global Hedge Fund D.E. Shaw Backs Boston Scientific as Top Healthcare Stock Pick
Global investment giant D.E. Shaw has identified Boston Scientific Corporation (BSX) as a high-potential stock for investors. The move highlights growing institutional confidence in medical technology firms as healthcare spending rises globally.
Global Healthcare Dividends: Why Pfizer Misses the Cut for Top Income Stocks
While healthcare stocks are often seen as safe havens for dividend seekers, recent market shifts have changed the outlook for major players. Experts are highlighting two specific healthcare stocks for their consistent payouts, while cautioning that former favorite Pfizer may no longer be the best choice for income-focused investors.
Shift From Broad Market Bets to Banking and Healthcare as Volatility Rises
With geopolitical tensions in West Asia impacting market stability, experts suggest moving away from broad index tracking. Investors are advised to focus on specific sectors like banking, healthcare, and industrials which show strong earnings potential for the coming years.
Mutual fund data is sourced from AMFI and shown for information only — funds are subject to market risks. Read all scheme-related documents carefully. Some listings may be sponsored. Not investment advice.